Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle (Q43614676)

25 November 2017

title

Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle (English)

1 reference

25 November 2017

Vander Lugt JT

1

1 reference

25 November 2017

Gómez-Márquez J

series ordinal

2

1 reference

25 November 2017

Caldon J

series ordinal

3

1 reference

25 November 2017

Louters LL

series ordinal

4

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

83

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

445-451

1 reference

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Mechanisms by which insulin and muscle contraction stimulate glucose transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Increased insulin-stimulated glucose uptake by exercised human muscles one day after prolonged physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Acute effects of troglitazone on in vivo insulin action in normal rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Nitric oxide in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Evidence that nitric oxide increases glucose transport in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

Nitric oxide release is present from incubated skeletal muscle preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901259-7

7 January 2021

10.1016/S0300-9084(01)01259-7

Identifiers

DOI

1 reference

release_akohav7z4jdkpg6t56di6hc67q

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/akohav7z4jdkpg6t56di6hc67q

24 November 2022

mapped directly with Wikidata item

1 reference